Evidence map›Paper›PMID 38921883›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Antifungal Activity of ZnO Nanoparticles Synthesized from

Rocío Vargas Hernández, Mayra A Alvarez Lemus, Susana De la Rosa García, Rosendo López González, Patricia Quintana, David García Zaleta, Viridiana Velázquez Vázquez, Sergio Gómez Cornelio

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Synthesis of zinc oxide nanoparticles usingFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rocío Vargas HernándezMultidisciplinary Academic Division of Jalpa de Méndez, Juarez Autonomous University of Tabasco, Jalpa de Méndez 86205, Tabasco, Mexico.ORCID 0009-0003-8597-7880
Mayra A Alvarez LemusNanotechnology Laboratory, Academic Division of Engineering and Architecture, Juarez Autonomous University of Tabasco, Cunduacán 86690, Tabasco, Mexico.ORCID 0000-0002-4883-7067
Susana De la Rosa GarcíaLaboratory of Applied Microbiology, Academic Division of Biological Sciences, Juarez Autonomous University of Tabasco, Villahermosa 86000, Tabasco, Mexico.ORCID 0000-0002-6654-4532
Rosendo López GonzálezNanotechnology Laboratory, Academic Division of Engineering and Architecture, Juarez Autonomous University of Tabasco, Cunduacán 86690, Tabasco, Mexico.ORCID 0000-0002-6850-8973
Patricia QuintanaNational Laboratory of Nano and Biomaterials, Department of Applied Physics, CINVESTAV-IPN, Cordemex, P.O. Box 73, Mérida 97310, Yucatán, Mexico.ORCID 0000-0002-8727-7605
David García ZaletaMultidisciplinary Academic Division of Jalpa de Méndez, Juarez Autonomous University of Tabasco, Jalpa de Méndez 86205, Tabasco, Mexico.ORCID 0000-0001-9953-9142
Viridiana Velázquez VázquezNanotechnology Laboratory, Academic Division of Engineering and Architecture, Juarez Autonomous University of Tabasco, Cunduacán 86690, Tabasco, Mexico.ORCID 0000-0002-5644-3842
Sergio Gómez CornelioNanotechnology Laboratory, Academic Division of Engineering and Architecture, Juarez Autonomous University of Tabasco, Cunduacán 86690, Tabasco, Mexico.ORCID 0000-0001-5102-9012

Funding

Consejo de Ciencia y Tecnología del Estado de Tabasco PRODECTI-2022-01/75
6 · The paper itself

Abstract

Fungal growth on construction materials in tropical climates can degrade aesthetics and manifestations on modern and historical sick buildings, affecting the health of their inhabitants. This study synthesized ZnO nanoparticles with enhanced antifungal properties using a precipitation method. Different concentrations (25%, 50%, and 100%) of

Indexed as

bio-assisted synthesisconstruction materialsfungicidal propertiesMIC/MFC ratiossick building syndrome

Identifiers

PMID38921883
PMCPMC11206371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.